Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial
Advances in Alzheimer's Disease · 2013
DOI: 10.4236/aad.2013.23012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Alzheimer's Disease, 2013. Verfasst von Timothy Nicholas und 10 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nicholas, T., Duvvuri, S., Leurent, C., Raunig, D., Rapp, T., Iredale, P., Rowinski, C., Carr, R., Roberts, P., Spiros, A., & Geerts, H. (2013). Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial. Advances in Alzheimer's Disease. https://doi.org/10.4236/aad.2013.23012
Vancouver
Nicholas T, Duvvuri S, Leurent C, Raunig D, Rapp T, Iredale P, et al. Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial. Advances in Alzheimer's Disease. 2013. doi:10.4236/aad.2013.23012
BibTeX
@article{Nicholas2013,
author = {Nicholas, Timothy and Duvvuri, Sridhar and Leurent, Claire and Raunig, David and Rapp, Tracey and Iredale, Phil and Rowinski, Carolyn and Carr, Robert and Roberts, Patrick and Spiros, Athan and Geerts, Hugo},
title = {Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial},
journal = {Advances in Alzheimer's Disease},
year = {2013},
doi = {10.4236/aad.2013.23012}
}
EUVIMED